Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/04/03 → 1/01/06 |
Funding
- UK-based charities: £762,698.00
11HSD1 as a therpaeutic target in metcbolic and neurodegenerative disease.
- Seckl, Jonathan (Principal Investigator)
- Walker, Brian (Co-investigator)